Sigma Healthcare Ltd (ASX: SIG) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Sigma Pharmaceuticals Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar. Market Cap $513.75 million
P/E Ratio 9.87
Dividend Yield 4.12%
Shares Outstanding 1.06 billion
Earnings per share -0.007
Dividend per share 0.03
Year To Date Return 3.13%
Earnings Yield 10.13%
Franking 100%
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Sigma Healthcare Ltd (ASX: SIG)
Latest News
Dividend Investing
Here’s a look at some ASX shares with ex-dividend dates coming up in April
Share Fallers
Why 88 Energy, Gold Road, Sigma, and Star shares are dropping
Healthcare Shares
Why has the Sigma (ASX:SIG) share price dived 14% so far in December?
Healthcare Shares
What’s the outlook for ASX healthcare shares in 2022?
Share Fallers
Why Appen, Cooper Energy, PolyNovo, and Sigma shares are falling
Share Fallers
Why Carsales, Magellan, Nickel Mines, and Sigma shares are dropping
Share Fallers
Why Bapcor, Kogan, Sigma, and Zip shares are dropping today
Healthcare Shares
Sigma (ASX:SIG) share price slides 7% to yearly low on guidance update
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 04 Apr 2022 | $0.0100 | 100.00% | Final | 22 Apr 2022 |
| 24 Sep 2021 | $0.0100 | 100.00% | Interim | 08 Oct 2021 |
| 06 Apr 2021 | $0.0100 | 100.00% | Final | 21 Apr 2021 |
| 19 Sep 2019 | $0.0100 | 100.00% | Interim | 04 Oct 2019 |
| 03 Apr 2019 | $0.0200 | 100.00% | Final | 29 Apr 2019 |
| 12 Oct 2018 | $0.0150 | 100.00% | Interim | 29 Oct 2018 |
| 05 Apr 2018 | $0.0250 | 100.00% | Final | 20 Apr 2018 |
| 19 Sep 2017 | $0.0250 | 100.00% | Interim | 05 Oct 2017 |
| 06 Apr 2017 | $0.0300 | 100.00% | Final | 21 Apr 2017 |
| 20 Sep 2016 | $0.0250 | 100.00% | Interim | 03 Oct 2016 |
| 06 Apr 2016 | $0.0300 | 100.00% | Final | 21 Apr 2016 |
| 23 Sep 2015 | $0.0200 | 100.00% | 07 Oct 2015 | |
| 31 Mar 2015 | $0.0100 | 100.00% | 16 Apr 2015 | |
| 31 Mar 2015 | $0.0200 | 100.00% | 16 Apr 2015 | |
| 03 Apr 2014 | $0.0200 | 100.00% | Final | 30 Apr 2014 |
| 21 Sep 2012 | $0.0200 | 100.00% | Interim | 26 Oct 2012 |
| 05 Apr 2011 | $0.1500 | 100.00% | Special Cash | 11 May 2011 |
| 16 Oct 2009 | $0.0300 | 100.00% | Interim | 13 Nov 2009 |
| 31 Mar 2009 | $0.0400 | 100.00% | Final | 07 May 2009 |
SIG ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Sigma Healthcare Ltd
Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy and 10% for hospitals. As a result, Sigma and its competitors, EBOS and API, are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.
SIG Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 13 May 2022 | $0.49 | $0.03 | 6.59% | 1,475,687 | $0.46 | $0.49 | $0.46 |
| 12 May 2022 | $0.46 | $-0.01 | -2.15% | 3,070,450 | $0.47 | $0.47 | $0.46 |
| 11 May 2022 | $0.47 | $0.00 | 0.00% | 965,070 | $0.47 | $0.47 | $0.46 |
| 10 May 2022 | $0.47 | $-0.01 | -2.08% | 1,787,177 | $0.47 | $0.48 | $0.47 |
| 09 May 2022 | $0.48 | $0.01 | 2.11% | 654,788 | $0.47 | $0.48 | $0.47 |
| 06 May 2022 | $0.48 | $-0.01 | -2.08% | 936,174 | $0.48 | $0.48 | $0.47 |
| 05 May 2022 | $0.48 | $0.00 | 0.00% | 379,952 | $0.49 | $0.49 | $0.48 |
| 04 May 2022 | $0.48 | $0.00 | 0.00% | 406,269 | $0.49 | $0.49 | $0.48 |
| 03 May 2022 | $0.48 | $-0.01 | -2.06% | 1,263,910 | $0.50 | $0.50 | $0.48 |
| 02 May 2022 | $0.49 | $-0.02 | -4.00% | 999,474 | $0.50 | $0.50 | $0.48 |
| 29 Apr 2022 | $0.50 | $0.03 | 6.38% | 1,986,251 | $0.47 | $0.50 | $0.47 |
| 28 Apr 2022 | $0.47 | $-0.01 | -2.11% | 487,942 | $0.48 | $0.48 | $0.47 |
| 27 Apr 2022 | $0.48 | $-0.01 | -2.08% | 858,818 | $0.48 | $0.49 | $0.47 |
| 26 Apr 2022 | $0.48 | $0.01 | 2.13% | 649,003 | $0.48 | $0.49 | $0.47 |
| 22 Apr 2022 | $0.47 | $-0.02 | -4.08% | 724,831 | $0.48 | $0.48 | $0.47 |
| 21 Apr 2022 | $0.49 | $0.01 | 2.08% | 532,494 | $0.49 | $0.49 | $0.48 |
| 20 Apr 2022 | $0.48 | $-0.01 | -2.06% | 669,310 | $0.50 | $0.50 | $0.48 |
| 19 Apr 2022 | $0.49 | $0.02 | 4.26% | 1,016,236 | $0.48 | $0.50 | $0.48 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 07 Apr 2022 | Christine Bartlett | Buy | 60 | $28,950 | On-market trade. |
| 01 Apr 2022 | David Manuel | Buy | 9 | $4,956 | Directors' share plan. |
| 01 Apr 2022 | Christine Bartlett | Buy | 10 | $5,286 | Directors' share plan. |
| 01 Apr 2022 | Michael Sammells | Buy | 10 | $5,286 | Directors' share plan. |
| 01 Apr 2022 | Kathryn (Kate) Spargo | Buy | 8 | $4,270 | Directors' share plan. |
| 01 Apr 2022 | Raymond Gunston | Buy | 18 | $9,581 | Directors' share plan. |
| 22 Dec 2021 | David Manuel | Buy | 11 | $5,244 | Directors' share plan. |
| 22 Dec 2021 | Raymond Gunston | Buy | 22 | $9,923 | Directors' share plan. |
| 22 Dec 2021 | Kathryn (Kate) Spargo | Buy | 14 | $6,376 | Directors' share plan. |
| 22 Dec 2021 | Michael Sammells | Buy | 12 | $5,524 | Directors' share plan. |
| 22 Dec 2021 | Christine Bartlett | Buy | 12 | $5,404 | Directors' share plan. |
| 30 Sep 2021 | Kathryn (Kate) Spargo | Buy | 8 | $5,102 | Directors' share plan. |
| 30 Sep 2021 | David Manuel | Buy | 9 | $5,821 | Directors' share plan. |
| 30 Sep 2021 | Christine Bartlett | Buy | 9 | $5,640 | Directors' share plan. |
| 30 Sep 2021 | Michael Sammells | Buy | 9 | $6,000 | Directors' share plan. |
| 30 Sep 2021 | Raymond Gunston | Buy | 17 | $10,607 | Directors' share plan. |
| 06 Jul 2021 | Michael Sammells | Buy | 9 | $6,000 | Directors' share plan. |
| 06 Jul 2021 | Christine Bartlett | Buy | 9 | $5,641 | Directors' share plan. |
| 06 Jul 2021 | David Manuel | Buy | 9 | $5,820 | Directors' share plan. |
| 06 Jul 2021 | Kathryn (Kate) Spargo | Buy | 8 | $5,101 | Directors' share plan. |
| 06 Jul 2021 | Raymond Gunston | Buy | 17 | $10,607 | Directors' share plan. |
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Ms Kathryn (Kate) Dianne Spargo | Non-Executive Director | Dec 2015 | Ms Spargo has gained business experience as both an adviser, having worked in private practice and government, and as a director of listed and unlisted companies. Ms Spargo is currently Non-Executive Director at Sonic Healthcare Limited, Adairs Limited, and CIMIC Ltd. Ms Spargo has held as Non-Executive Director in Xenith IP Ltd and Fletcher Building Limited. In addition, Ms Spargo's current positions in unlisted companies include Chairman of CoInvest and Director at the Geelong Football Club and Future Fuels Cooperative Research Centre. She is a Member of Risk Management and People committee. |
| Mr Raymond Mark Gunston | Non-Executive DirectorNon-Executive Chairman | Jul 2010 | Mr Gunston is a Non-Executive Director and Chairman of the Board of Hotel Property Investments Limited. He has over 40 years of corporate and financial services experience in the public and private sectors, specialising in finance, treasury, mergers and acquisitions, and accounting. He is a former Chief Financial Officer of Tatts Group Limited, and of the Australian Football League, a former Director of many of the Tatts Group's subsidiary and associate companies, and the former Interim CEO for the Essendon AFL Football Club. |
| Mr David Gerald Manuel | Non-Executive Director | Oct 2009 | Mr Manuel has an participant in industry affairs with a special interest in cognitive services such as opiate dependency treatments, compounding, medical technology and aged care pharmacy services. Mr Manuel is a Director of Alchemy Healthcare Pty Ltd, Black Swan Healthcare Ltd, and Elements Health Care Pty Ltd. He is a current Western Australian representative on the Amcal Guardian National Council (AGNC) and a current Branch Committee Member of The Pharmacy Guild of Australia (WA Branch). He is a member of the People and the Risk Management Committee. |
| Ms Christine Nildra Bartlett | Non-Executive Director | Mar 2016 | Ms Bartlett as an experienced CEO and senior executive has commercial expertise, with a focus in areas of financial discipline, risk management, innovation, technology, and strategy execution. Ms Bartlett's current directorships in listed entities include Non-Executive Director at Mirvac Group and Reliance Worldwide Corporation Ltd. Ms Bartlett resigned as a Director of GBST Ltd in November 2019. She is a Chair of People Committee. |
| Mr Michael Sammells | Non-Executive Director | Feb 2020 | Mr Sammells is currently a NonExecutive Director at AMP. Mr Sammells has 35 years of experience in finance, corporate services, and has held operational roles with expertise in finance, accounting, treasury, investor relations, capital developments, mergers and acquisitions and IPOs. Mr Sammells is a former Chief Financial Officer of Healthscope Limited and Medibank Private. He is a Chair of Risk Management Committee. |
| Mr Vikesh Ramsunder | Chief Executive OfficerManaging Director | Feb 2022 | Mr Ramsunder was previously Group CEO of Clicks Group in South Africa, a position he held since January 2019. Prior to becoming Group CEO, Vikesh held a number of roles within the Clicks Group, including Chief Operating Officer from 2015, and Managing Director of United Pharmaceutical Distributors (UPD), the Click Group's pharmaceutical wholesale and distribution division. |
| Ms Kara McGowan | General CounselCompany Secretary | Oct 2021 | - |
| Kara McGowan | General CounselCompany Secretary | - | |
| J Sells | Executive General Manager Retail Pharmacy Interim Chief Financial Officer | - |
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Citicorp Nominees Pty Limited | 207,368,837 | 19.58% |
| HSBC Custody Nominees (Australia) Limited | 186,194,116 | 17.58% |
| J P Morgan Nominees Australia Pty Limited | 119,543,560 | 11.29% |
| National Nominees Limited | 44,625,366 | 4.21% |
| Pacific Custodians Pty Limited | 41,901,785 | 3.96% |
| Sigma Employee Share Admin P/L | 30,522,244 | 2.88% |
| Bnp Paribas Nominees Pty Ltd | 27,013,845 | 2.55% |
| BNP Paribas Noms Pty Ltd | 22,953,760 | 2.17% |
| HSBC Custody Nominees (Australia) Limited (i) | 22,757,918 | 2.15% |
| Mr Mark Robert Hooper | 11,860,636 | 1.12% |
| Bnp Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd | 3,998,705 | 0.38% |
| Jeffrey Sells | 3,602,441 | 0.34% |
| Etiam Pty Limited | 3,114,371 | 0.29% |
| BNP Paribas Nominees Pty Ltd Six Sis Ltd | 2,905,208 | 0.27% |
| Citicorp Nominees Pty Limited (i) | 2,419,916 | 0.23% |
| BNP Paribas Nominees Pty Ltd Acf Clearstream | 2,310,068 | 0.22% |
| Bnp Paribas Nominees Pty Ltd (i) | 2,230,804 | 0.21% |
| Mrs Trudie Anne Hooper | 2,000,000 | 0.19% |
| Nabru Nominees Pty Limited | 1,500,000 | 0.14% |
| Mr Peter Urban | 1,438,262 | 0.14% |